Results 1 to 10 of about 266,976 (313)

Tobacco Mosaic Viral Nanoparticle Inhibited Osteoclastogenesis Through Inhibiting mTOR/AKT Signaling

International Journal of Nanomedicine, 2020
Zhongshu Shan,1,2,* Hongtao Bi,3,* Angxiu Suonan,2 Yong Gu,1 Huan Zhou,4 Kun Xi,1 Rui Xiong,5 Hua Chen,2 Liang Chen1 1Department of Orthopedic Surgery, The 1st Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People’s Republic of China ...
Shan Z, Bi H, Suonan A, Gu Y, Zhou H, Xi K, Xiong R, Chen H, Chen L   +8 more
doaj  

Gene Expression Studies to Identify Significant Genes in AR, MTOR, MAPK Pathways and their Overlapping Regulatory Role in Prostate Cancer

Journal of Integrative Bioinformatics, 2019
Gene expression studies revealed a large degree of variability in gene expression patterns particularly in tissues even in genetically identical individuals. It helps to reveal the components majorly fluctuating during the disease condition.
Asati Nimisha, Mishra Abhinav, Shukla Ankita, Singh Tiratha Raj   +3 more
doaj   +1 more source

Erratum: Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor [PDF]

, 2016
A Carpentieri, E Cozzoli, M Scimeca, Elena Bonanno, Anna Maria Sardanelli, Alessandra Gambacurta   +5 more
openalex   +1 more source

Data from Inducible Nitric Oxide Synthase Drives mTOR Pathway Activation and Proliferation of Human Melanoma by Reversible Nitrosylation of TSC2

, 2023
Esther López-Rivera, Padmini Jayaraman, Falguni Parikh, Michael A. Davies, Sühendan Ekmekçioglu, Sudeh Izadmehr, Denái R. Milton, Jerry E. Chipuk, Elizabeth A. Grimm, Yeriel Estrada, Julio A. Aguirre‐Ghiso, Andrew G. Sikora   +11 more
openalex   +1 more source

Inhibition of mTOR signaling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation [PDF]

, 2015
Danfeng Sun, Yan‐jie Zhang, Xiaoqing Tian, Yingxuan Chen, Jing‐Yuan Fang   +4 more
openalex   +1 more source

Supplementary Tables 1-3 from Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases

, 2023
Anna Tamburrino, Alfredo A. Molinolo, Paolo Salerno, Rebecca D. Chernock, Mark Raffeld, Liqiang Xi, J. Silvio Gutkind, Jeffrey F. Moley, Samuel A. Wells, Massimo Santoro   +9 more
openalex   +1 more source

Supplementary Methods from ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAP

, 2023
Taru Muranen, Laura M. Selfors, Julie Chernov Hwang, Lisa L. Gallegos, Jonathan L. Coloff, Carson C. Thoreen, Seong A. Kang, David M. Sabatini, Gordon B. Mills, Joan S. Brugge   +9 more
openalex   +1 more source

Supplimentary_Figure1-14 and Table 1-2 from Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma

, 2023
Xinhua Song, Xianqiong Liu, Haichuan Wang, Jingxiao Wang, Qiao Yu, Antonio Cigliano, Kirsten Utpatel, Silvia Ribback, Maria G. Pilo, Marina Serra, John D. Gordan, Li Che, Shanshan Zhang, Antonio Cossu, Alberto Porcu, Rosa M. Pascale, Frank Dombrowski, Hongbo Hu, Diego F. Calvisi, Matthias Evert, Xin Chen   +20 more
openalex   +1 more source

Figure S4 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer [PDF]

, 2023
Jonathan M. Cooper, Yi-Hung Ou, Elizabeth A. McMillan, Rachel M. Vaden, Aubhishek Zaman, Brian O. Bodemann, Gurbani Makkar, Bruce A. Posner, Michael A. White   +8 more
openalex   +1 more source

Emodin-Induced Autophagy Against Cell Apoptosis Through the PI3K/AKT/mTOR Pathway in Human Hepatocytes [Corrigendum]

Drug Design, Development and Therapy, 2022
Zheng X, Yang S, Zhang R, Wang S, Li G, Zhou S. Drug Des Devel Ther. 2019;13:3171–3180. The authors have advised due to an error that occurred inadvertently at the time of figure assembly, Figure 5J is incorrect.
Zheng X, Yang S, Zhang R, Wang S, Li G, Zhou S   +5 more
doaj